Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Preferred Shares Issued (2023)

LENZ Therapeutics (LENZ) has disclosed Preferred Shares Issued for 1 consecutive years, with $17.0 million as the latest value for Q2 2023.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $17.0 million in Q2 2023 year-over-year; TTM through Dec 2023 was $83.0 million, a N/A change, with the full-year FY2023 number at $83.0 million, changed N/A from a year prior.
  • Preferred Shares Issued was $17.0 million for Q2 2023 at LENZ Therapeutics, down from $66.0 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $66.0 million in Q1 2023 to a low of $17.0 million in Q2 2023.